SUBSCRIBE
SUBSCRIBE
News   Business

MannKind Corporation Says No Afresa Partnership In 2009

October 7, 2009 | 
1 min read
Reuters - MannKind Corp (MNKD.O) said it would be unable to conclude a partnership deal for its inhaled insulin product, Afresa, by year-end as it plans to wait for the U.S. health regulator's response on its new drug application for the product.
Alliances
MORE ON THIS TOPIC
Pictured: Roche tower in Basel, Switzerland
Manufacturing
Roche Seeks Antibiotic Partner as Rising Manufacturing Costs Drive Supply Rethink
February 24, 2026
 · 
1 min read
 · 
Nick Paul Taylor
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Generate’s IPO Could Reach $425M, Largest Raise Yet
February 24, 2026
 · 
5 min read
 · 
Tristan Manalac
Manual worker with protective work gloves holding a yellow safety helmet on a yellow and orange background with copy space and reflections. Concept of workplace security.
Manufacturing
AbbVie Backs Obesity Push With $380M API Production Expansion Project in Illinois
February 24, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Collage image of people arms gloves hold equipment hit hammer cut saw nail gun isolated on creative white background.
Executive appointments
Merck Reorganizes Human Health Work Into Two New Units
February 23, 2026
 · 
1 min read
 · 
Annalee Armstrong